86 related articles for article (PubMed ID: 22116627)
1. Association of NQO1 Pro187Ser polymorphism with the risks for colorectal cancer and colorectal adenoma: a meta-analysis.
Zhou JY; Shi R; Yu HL; Zheng WL; Ma WL
Int J Colorectal Dis; 2012 Aug; 27(8):1123-4. PubMed ID: 22116627
[No Abstract] [Full Text] [Related]
2. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.
Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG
Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
4. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma.
Hou L; Chatterjee N; Huang WY; Baccarelli A; Yadavalli S; Yeager M; Bresalier RS; Chanock SJ; Caporaso NE; Ji BT; Weissfeld JL; Hayes RB
Carcinogenesis; 2005 Jun; 26(6):1122-8. PubMed ID: 15731166
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians.
Zhao H; Zhu F; Sun J; Meng X
Tumour Biol; 2014 Mar; 35(3):2111-6. PubMed ID: 24142528
[TBL] [Abstract][Full Text] [Related]
6. Letter to the editor: a meta-analyses of association between polymorphism of MTHFR A1298C and colorectal cancer risk.
Ge H; Zheng X; Zhao E; Sheng X; Lu S; Cheng S; Yu J
Int J Colorectal Dis; 2012 Oct; 27(10):1387-8. PubMed ID: 22350268
[No Abstract] [Full Text] [Related]
7. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis.
Yuan W; Xu L; Chen W; Wang L; Fu Z; Pang D; Li D
Breast Cancer Res Treat; 2011 Jan; 125(2):467-72. PubMed ID: 20526805
[TBL] [Abstract][Full Text] [Related]
8. Role of MTHFR C677T polymorphism in systemic carcinogenesis, besides its role in the pathogenesis of colo-rectal carcinomas.
Kapoor S
Genet Mol Res; 2012 Sep; 11(3):3365-6. PubMed ID: 23079830
[No Abstract] [Full Text] [Related]
9. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.
Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA
Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958
[TBL] [Abstract][Full Text] [Related]
10. NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristics of human mammary tumors.
Hubackova M; Vaclavikova R; Mrhalova M; Kubackova K; Kodet R; Gut I; Soucek P
Pharmacogenet Genomics; 2009 Jul; 19(7):505-12. PubMed ID: 19494791
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the association between the XRCC1 gene R399Q polymorphism and colorectal cancer: an update.
Wu W; Wu Y; Wang M; Zhang D
Int J Colorectal Dis; 2013 Oct; 28(10):1453-4. PubMed ID: 23233244
[No Abstract] [Full Text] [Related]
12. NQO1 and mEH exon 4 (mEH4) gene polymorphisms, smoking and colorectal cancer risk.
Mitrou P; Watson M; Bingham S; Stebbings WS; Speakman CT; Loktionov A
IARC Sci Publ; 2002; 156():495-7. PubMed ID: 12484241
[No Abstract] [Full Text] [Related]
13. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.
Ding R; Lin S; Chen D
Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148
[TBL] [Abstract][Full Text] [Related]
14. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
[TBL] [Abstract][Full Text] [Related]
15. Correlative polymorphism of NAD(P)H: quinone oxidoreductase (NQO1) with telomere shortening in colorectal cancer.
Takagi S; Kinouchi Y; Hiwatashi N; Hirai M; Suzuki S; Takahashi S; Negoro K; Obana N; Shimosegawa T
Anticancer Res; 2002; 22(5):2749-52. PubMed ID: 12529991
[TBL] [Abstract][Full Text] [Related]
16. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
[TBL] [Abstract][Full Text] [Related]
17. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
[TBL] [Abstract][Full Text] [Related]
18. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
19. The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.
Tijhuis MJ; Boerboom AM; Visker MH; Op den Camp L; Nagengast FM; Tan AC; Rietjens IM; Kok FJ; Aarts JM; Kampman E
Nutr Cancer; 2008; 60(2):204-15. PubMed ID: 18444152
[TBL] [Abstract][Full Text] [Related]
20. Low-penetrance genes and their involvement in colorectal cancer susceptibility.
de Jong MM; Nolte IM; te Meerman GJ; van der Graaf WT; de Vries EG; Sijmons RH; Hofstra RM; Kleibeuker JH
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1332-52. PubMed ID: 12433710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
